52.10
+1.38(+2.72%)
Currency In USD
| Previous Close | 50.72 |
| Open | 50.06 |
| Day High | 53.1 |
| Day Low | 49.98 |
| 52-Week High | 90.32 |
| 52-Week Low | 41.5 |
| Volume | 744,304 |
| Average Volume | 2.12M |
| Market Cap | 2.8B |
| PE | -29.77 |
| EPS | -1.75 |
| Moving Average 50 Days | 58 |
| Moving Average 200 Days | 66.96 |
| Change | 1.38 |
If you invested $1000 in Soleno Therapeutics, Inc. (SLNO) 10 years ago, it would be worth $69.92 as of December 04, 2025 at a share price of $52.1. Whereas If you bought $1000 worth of Soleno Therapeutics, Inc. (SLNO) shares 5 years ago, it would be worth $359.93 as of December 04, 2025 at a share price of $52.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
GlobeNewswire Inc.
Yesterday at 9:05 PM GMT
REDWOOD CITY, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today regrets to announce the passing of Willia
Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 24, 2025 1:00 PM GMT
REDWOOD CITY, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D., C
Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
GlobeNewswire Inc.
Nov 11, 2025 12:00 PM GMT
REDWOOD CITY, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that its Board of Directors h